In line with Dalton's ongoing mission to adopt cutting-edge technology, this strategic investment not only expands the collaboration between the two organisations, but it also enables Toronto-based ...

The acquisition of 3P innovation's RFF Cell enables Dalton to address larger segments of the pharmaceutical market and serve customers with greater global patient populations. TORONTO — Pharmaceutical ...

Dalton Pharma Services has announced expanded cGMP sterile powder filling capabilities as part of its ongoing focus on sterile processing and manufacturing. The expansion includes the addition of a ...

Dry-powder inhalers (DPIs) are complex multifaceted systems designed to reproducibly deliver an efficacious dose of medicine in an appropriate, aerodynamic range of sizes to enable the treatment of ...

TORONTO, June 5, 2024 /CNW/ -- Pharmaceutical manufacturing company, Dalton Pharma Services (a Seikagaku Group company), has recently commissioned 3P innovation (Warwick, UK) to design and construct a ...